Nanotechnology for Cancer Therapy Based on Chemotherapy
AbstractChemotherapy has been widely applied in clinics. However, the therapeutic potential of chemotherapy against cancer is seriously dissatisfactory due to the nonspecific drug distribution, multidrug resistance (MDR) and the heterogeneity of cancer. Therefore, combinational therapy based on chemotherapy mediated by nanotechnology, has been the trend in clinical research at present, which can result in a remarkably increased therapeutic efficiency with few side effects to normal tissues. Moreover, to achieve the accurate pre-diagnosis and real-time monitoring for tumor, the research of nano-theranostics, which integrates diagnosis with treatment process, is a promising field in cancer treatment. In this review, the recent studies on combinational therapy based on chemotherapy will be systematically discussed. Furthermore, as a current trend in cancer treatment, advance in theranostic nanoparticles based on chemotherapy will be exemplified briefly. Finally, the present challenges and improvement tips will be presented in combination therapy and nano-theranostics. View Full-Text
Share & Cite This Article
Zhao, C.-Y.; Cheng, R.; Yang, Z.; Tian, Z.-M. Nanotechnology for Cancer Therapy Based on Chemotherapy. Molecules 2018, 23, 826.
Zhao C-Y, Cheng R, Yang Z, Tian Z-M. Nanotechnology for Cancer Therapy Based on Chemotherapy. Molecules. 2018; 23(4):826.Chicago/Turabian Style
Zhao, Chen-Yang; Cheng, Rui; Yang, Zhe; Tian, Zhong-Min. 2018. "Nanotechnology for Cancer Therapy Based on Chemotherapy." Molecules 23, no. 4: 826.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.